Ethylsulfonated hyaluronic acid biopolymers and methods of use thereof

US10000582B2 · kind B2 · utility

Assignee

• The Regents of the University of California · US

Inventors

• Amit Kumar Jha · Noida, IN
• Eda Isil Altiok · Berkeley, US
• Wesley M. Jackson · Albany, US
• Kevin E. Healy · Moraga, US

Key dates

• Filing date: Apr 1, 2014
• Grant date: Jun 19, 2018
• Expiry date: Oct 7, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2533/80
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure provides methods for sulfonation of hyaluronic acid. The present disclosure provides sulfonated hyaluronic acid, and compositions, including pharmaceutical compositions, comprising the sulfonated hyaluronic acid. The present disclosure provides implantable materials and drug delivery compositions comprising a subject sulfonated hyaluronic acid.